SCHEMBL45099

SCHEMBL45099

O=C(O)c1cccc(-c2ncc[nH]2)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.68
ALDH1A1 P00352 3/20 0.68
MTOR P42345 1/20 0.59
ADK P55263 1/20 0.59
NISCH Q9Y2I1 1/20 0.59
NPC1 O15118 1/20 0.56
HPGD P15428 1/20 0.56
RAB9A P51151 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
CD74 P04233 1/20 0.54
MIF P14174 1/20 0.54
KMO O15229 2/20 0.53
VCP P55072 1/20 0.52
KDM4C Q9H3R0 1/20 0.49
RXRA P19793 1/20 0.47
RXRB P28702 1/20 0.47
DDT P30046 1/20 0.47
MAPK1 P28482 1/20 0.47
MAP2K4 P45985 1/20 0.47
MAPKAPK3 Q16644 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29569789 1.00 KDM4E (0.68) KDM4EALDH1A1MTORADKNISCH
SCHEMBL5481767 0.85 PRKCI (0.55) KDM4EALDH1A1MTORADKNISCH
SCHEMBL12647965 0.85 NISCH (0.53) KDM4EALDH1A1MTORADKNISCH
SCHEMBL6610117 0.83 VCP (0.53) KDM4EALDH1A1MTORADKNISCH
SCHEMBL3062520 0.83 KDM4E (0.70) KDM4EALDH1A1MTORADKNISCH
SCHEMBL28424340 0.82 KDM4E (0.71) KDM4EALDH1A1MTORADKNISCH
2-Phenylimidazole SCHEMBL28482306 0.82 KDM4E (0.66) KDM4EALDH1A1MTORADKNISCH
2-Phenylimidazole SCHEMBL11649145 0.82 KDM4E (0.66) KDM4EALDH1A1MTORADKNISCH
SCHEMBL16777437 0.82 NISCH (0.72) KDM4EALDH1A1MTORADKNISCH
SCHEMBL4069529 0.82 KDM4E (0.50) KDM4EALDH1A1NPC1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3693434-B1 ADHESIVE COMPOSITION FOR SEMICONDUCTOR CIRCUIT CONNECTION AND ADHESIVE FILM INCLUDING THE SAME LG CHEMICAL LTD (KR) 2025-10-08 EP disclosed
US-12006308-B2 Adhesive composition for semiconductor circuit connection and adhesive film containing the same LG CHEM, LTD. (KR) 2024-06-11 US disclosed
US-11834415-B2 Adhesive composition for semiconductor circuit connection and adhesive film including the same LG CHEM, LTD. (KR) 2023-12-05 US disclosed
CN-111836840-B Adhesive composition for semiconductor circuit connection and adhesive film comprising the same 株式会社LG化学 2022-04-15 CN disclosed
CN-111448276-B Adhesive composition for semiconductor circuit connection and adhesive film comprising the same 株式会社LG化学 2021-11-30 CN disclosed
US-20210115021-A1 ADHESIVE COMPOSITION FOR SEMICONDUCTOR CIRCUIT CONNECTION AND ADHESIVE FILM CONTAINING THE SAME LG CHEM, LTD. (KR) 2021-04-22 US disclosed
EP-3763709-A1 ADHESIVE COMPOSITION FOR CONNECTING SEMICONDUCTOR CIRCUIT, AND ADHESIVE FILM COMPRISING SAME LG CHEM, LTD. (KR) 2021-01-13 EP disclosed
CN-111836840-A Adhesive composition for semiconductor circuit connection and adhesive film comprising the same 株式会社LG化学 2020-10-27 CN disclosed
US-20200308121-A1 ADHESIVE COMPOSITION FOR SEMICONDUCTOR CIRCUIT CONNECTION AND ADHESIVE FILM INCLUDING THE SAME LG CHEM, LTD. (KR) 2020-10-01 US disclosed
EP-3693434-A1 ADHESIVE COMPOSITION FOR SEMICONDUCTOR CIRCUIT CONNECTION, AND ADHESIVE FILM COMPRISING SAME LG CHEM, LTD. (KR) 2020-08-12 EP disclosed
WO-2009112826-A1 FURO [3, 2-B] PYRR0L-3-0NES AS CATHEPSIN S INHIBITORS AMURA THERAPEUTICS LIMITED (GB) 2009-09-17 WO disclosed
EP-2097420-A1 SPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS Pfizer Products Inc. (US) 2009-09-09 EP disclosed
WO-2008065508-A1 SPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS PFIZER PRODUCTS INC. (US) 2008-06-05 WO disclosed
CN-1759095-A N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives ELAN PHARM INC (US) 2006-04-12 CN disclosed
EP-0931060-A4 SUBSTITUTED N- (AMINOIMINOMETHYL OR AMINOMETHYL)PHENYL]PROPYL AMIDES AVENTIS PHARMA INC (US) 2004-10-06 EP disclosed
US-20030232860-A1 Medicine comprising dicyanopyridine derivative ASTELLAS PHARMA INC. (JP) 2003-12-18 US disclosed
CN-1441783-A Drug containing dicyanopyridine derivative YAMANOUCHI PHARMA CO LTD (JP) 2003-09-10 CN disclosed
EP-1302463-A1 MEDICINE COMPRISING DICYANOPYRIDINE DERIVATIVE YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2003-04-16 EP disclosed
EP-0931060-A1 SUBSTITUTED N- (AMINOIMINOMETHYL OR AMINOMETHYL)PHENYL]PROPYL AMIDES RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-07-28 EP disclosed
WO-1999000356-A1 SUBSTITUTED N-[(AMINOIMINOMETHYL OR AMINOMETHYL)PHENYL]PROPYL AMIDES RHÔNE-POULENC RORER PHARMACEUTICALS INC. (US) 1999-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12006308-B2 Adhesive composition for semiconductor circuit connection and adhesive film containing the same ASH2L, SMARCC1, SMARCC2 KDM4E 837/4885ALDH1A1 1836/4885MTOR 957/4885
US-20030232860-A1 Medicine comprising dicyanopyridine derivative KCNN3, KCNN2, KCNN1 KDM4E 369/4885ALDH1A1 3292/4885MTOR 3727/4885
US-20200308121-A1 ADHESIVE COMPOSITION FOR SEMICONDUCTOR CIRCUIT CONNECTION AND ADHESIVE FILM INCLUDING THE SAME ASH2L, CDH1, AS3MT KDM4E 843/4885ALDH1A1 1953/4885MTOR 2395/4885
US-11834415-B2 Adhesive composition for semiconductor circuit connection and adhesive film including the same ASH2L, CDH1, AS3MT KDM4E 843/4885ALDH1A1 1953/4885MTOR 2395/4885
US-20210115021-A1 ADHESIVE COMPOSITION FOR SEMICONDUCTOR CIRCUIT CONNECTION AND ADHESIVE FILM CONTAINING THE SAME ASH2L, SMARCC1, SMARCC2 KDM4E 837/4885ALDH1A1 1836/4885MTOR 957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.